METHOD FOR PREPARING DRUG BASED ON HIGHER AFFINITY OF ACTIVE AGENTS TO CRYSTALLINE MICROPARTICLE SURFACES Russian patent published in 2010 - IPC A61J3/00 A61K9/16 A61K38/00 A61K47/22 

Abstract RU 2390325 C2

FIELD: medicine.

SUBSTANCE: invention refers to methods for adsorption of an active agent representing protein or peptide, on a surface in a pre-formed crystalline diketopiperasine microparticles which includes the stage: modifying of chemical potential of the active agent which provides energy-favourable reaction of the active agent and the diketopiperasine microparticle and does not include solvent removal, and the stage of adsorption of the active agent on a surface of the pre-formed crystalline diketopiperasine microparticle. The modifying stage of chemical potential includes change of the solution medium by adding a modifier of the active agent to the solution.

EFFECT: higher adsorption of the active agent on the surfaces of the microparticle with reduced tendency to remain in the solution.

31 cl, 17 dwg, 7 ex

Similar patents RU2390325C2

Title Year Author Number
PHARMACEUTICAL COMPOSITIONS, CONTAINING GLUCAGON-LIKE PEPTIDE (GLP-1) 2007
  • Grin Stefani
  • Brandt Dehvid
  • Gel'Ber Kokhava
  • King Mark
  • Chizam Vehjman Vehndell
  • Oberg Kit
  • Leone-Behj Andrea
  • Khoukenson Mark Dzh.
  • Fejris Mehri
RU2409349C2
PHARMACEUTICAL COMPOSITIONS, CONTAINING GLUCAGON-LIKE PEPTIDE 1 (GLP-1) 2007
  • Grin Stefani
  • Brandt Dehvid
  • Gel'Ber Kokhava
  • King Mark
  • Chizam Vehjman Vehndell
  • Oberg Kit
  • Leone-Behj Andrea
  • Khoukenson Mark Dzh.
  • Fejris Mehri
RU2542500C2
METHOD FOR PREPARING DRUG COMPOSITION BASED ON INCREASING ACTIVE AGENT AFFINITY OF CRYSTALLINE MICROPARTICLE SURFACES 2010
  • Oberg Kit A.
RU2443414C2
METHOD OF OBTAINING MEDICAL COMPOSITION, BASED ON INCREASE OF CRYSTAL MICRO PARTICLES SURFACE AFFINITY TO ACTIVE AGENTS 2006
  • Oberg Kit A.
RU2394550C2
METHOD FOR PREVENTING GLP-1 SIDE EFFECTS 2008
  • Richardson Piter
  • Boumen Robert A.
  • Kostello Donal'D
RU2474415C2
ACTIVE SUBSTANCE DELIVERY 2008
  • Boumen Robert A.
  • Richardson Piter
  • Kostello Donal'D
  • Leone-Behj Andrea
RU2467741C2
DIKETOPIPERAZINE MICROPARTICLES WITH PARTICULAR SPECIFIC SURFACE AREAS 2010
  • Grant Marshall L.
  • Stouehll Grejson U.
  • Menkin Pol
RU2509555C2
DIKETOPIPERAZIN MICROPARTICLES WITH PARTICULAR AMOUNT OF ISOMERS 2010
  • Kraft Kelli S.
  • Somervill Karla
RU2490026C1
METHOD OF IMPROVING PHARMACEUTICAL PROPERTIES OF PARTICLES, CONTAINING DIKETOPIPERAZINE AND ACTIVE AGENT 2007
  • Uilson Brajan R.
  • Grant Marshall
RU2403059C2
DRY POWDER DRUG DELIVERY SYSTEMS AND METHODS 2013
  • Smatni Chad S.
  • Adamo Benua
  • Laurentsi Brendan F.
  • Kinsi P. Spenser
RU2650035C2

RU 2 390 325 C2

Authors

Khouknson Mark

Oberg Kit A.

Dates

2010-05-27Published

2006-09-14Filed